Novozymes A/S (NVZMY) Stock Chart & Stock Price History $74.89 -0.58 (-0.77%) As of 06/13/2025 03:59 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartDividendHeadlinesSEC FilingsShort InterestBuy This Stock Novozymes A/S Stock Price Performance The Novozymes A/S (NVZMY) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 28.25%, with a year-to-date return of 32.46%. In the past month, the stock has increased 12.96%, reflecting recent market activity. As of the latest close, Novozymes A/S traded at $74.89 with a market cap of $35.07 billion and volume of 14,670 shares. Five years ago, the stock traded at $56.34, representing a 32.93% increase over that period. At the time, it had a market cap of $16.68 billion and a volume of 14,384 shares. Receive NVZMY Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Novozymes A/S and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+2.00%1 Month Performance+12.96%3 Month Performance+24.01%Year-To-Date Performance+32.46%1 Year Performance+28.25%5 Year Performance+32.93% NVZMY Stock Chart for Saturday, June, 14, 2025 NVZMY Chart by TradingView Novozymes A/S Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/13/2025$75.47$74.89-0.77%$75.59$73.7614,670 shs$35.07 billion06/12/2025$74.76$75.47+0.95%$75.88$75.328,143 shs$35.34 billion06/11/2025$73.88$74.76+1.19%$75.17$74.015,472 shs$35.01 billion06/10/2025$73.42$73.88+0.63%$74.10$73.6012,113 shs$34.60 billion06/09/2025$72.98$73.42+0.60%$75.40$72.5031,651 shs$34.38 billion06/06/2025$71.67$72.98+1.83%$74.20$71.6546,047 shs$34.18 billion06/05/2025$72.16$71.67-0.68%$74.14$70.8636,692 shs$33.56 billion06/04/2025$70.29$72.16+2.66%$72.33$70.7920,898 shs$33.79 billion06/03/2025$71.74$70.29-2.02%$70.49$70.1111,411 shs$32.92 billion06/02/2025$70.85$71.74+1.26%$72.77$70.7682,091 shs$33.60 billion Get the Latest News and Ratings for NVZMY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Novozymes A/S and its competitors with MarketBeat's FREE daily newsletter. 05/30/2025$70.45$70.85+0.57%$72.03$69.1541,132 shs$33.18 billion05/29/2025$69.83$70.45+0.89%$71.55$68.2437,287 shs$32.99 billion05/28/2025$70.87$69.83-1.47%$70.34$69.67522,001 shs$32.70 billion05/27/2025$69.75$70.87+1.61%$71.53$70.5975,587 shs$33.19 billion05/26/2025$69.75$69.75$70.86$69.05157,383 shs$32.66 billion05/23/2025$70.43$69.75-0.97%$70.86$69.05157,383 shs$32.66 billion05/22/2025$70.09$70.43+0.49%$70.43$69.8112,234 shs$32.98 billion05/21/2025$68.93$70.09+1.68%$70.65$69.397,843 shs$32.82 billion05/20/2025$68.44$68.93+0.72%$68.93$67.468,096 shs$32.28 billion05/19/2025$68.49$68.44-0.07%$70.17$66.8513,938 shs$32.05 billion05/16/2025$67.12$68.49+2.04%$68.50$65.394,852 shs$32.07 billion05/15/2025$66.30$67.12+1.24%$68.80$66.0512,195 shs$31.43 billion05/14/2025$66.00$66.30+0.45%$68.32$65.517,024 shs$31.05 billion05/13/2025$65.28$66.00+1.10%$66.06$63.3813,015 shs$30.91 billion Related Companies Gilead Sciences Stock Chart argenx Stock Chart BioNTech Stock Chart Biogen Stock Chart Neurocrine Biosciences Stock Chart Exelixis Stock Chart Moderna Stock Chart Qiagen Stock Chart Bio-Techne Stock Chart Revolution Medicines Stock Chart Receive NVZMY Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Novozymes A/S and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:NVZMY) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredOil Hits $74 - $100 Next?Oil Jumps 8.5% on Middle East Crisis Trump at Oil Fields Oil surged 8.5% to $74/barrel after Israel's Ir...The Oxford Club | SponsoredGet in stocks now - and get out on this dateGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novozymes A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Novozymes A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NVZMY Stock Free NVZMY Stock Alerts